Robert William Georgantas III

Robert William Georgantas III, listed as senior executive, appears in our data through filings on Biodesix Inc shares, published by SEC (Form 4). Between 30 October 2020 and 21 November 2022, the trades on record add up to 11 filings.

Both buying and selling appear: 2 purchases worth €10k, against 4 sales worth €9,482. Taken together, the purchases exceed the sales by €613. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Outside the open market, there are 1 share grant and 4 option exercises. 2022 to date brings no purchases and 4 sales.

On 21 November 2022 came the latest disclosure, a share grant for €13k in Biodesix Inc. The last insider purchase was made public on 3 November 2020, 2,197 days ago. Typically, a trade is published a median of 2 days after it takes place. For comparison, the SEC allows two business days to file a Form 4. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.